93653

Comprehensive electrophysiologic evaluation and ablation for AVNRT, AVRT, and/or focal atrial tachycardia, extensive, with 3D mapping

This CPT code describes a comprehensive electrophysiologic (EP) study followed by catheter ablation for specific types of supraventricular tachycardias (SVTs). It involves the percutaneous insertion and precise repositioning of multiple electrode catheters within the cardiac chambers and great vessels to record intracardiac electrograms and map the electrical activity. The procedure includes the induction or attempted induction of arrhythmia to confirm the diagnosis and delineate the arrhythmogenic substrate. The target arrhythmias for this extensive service are Atrioventricular Nodal Re-entry Tachycardia (AVNRT), Atrioventricular Re-entry Tachycardia (AVRT), which includes Wolff-Parkinson-White (WPW) Syndrome, and/or focal atrial tachycardia. A key component is the use of intracardiac electrophysiologic 3D mapping systems to create detailed anatomical and electrical maps of the heart, guiding the precise delivery of radiofrequency or cryoablation energy. The ablation targets an accessory pathway (for AVRT/WPW), an atrial focus (for focal atrial tachycardia), or an AV nodal re-entrant pathway (for AVNRT). This code explicitly states "without right atrial pacing and recording," meaning these basic components are either not performed or are considered inclusive to the comprehensive nature of the procedure when 93653 is reported.

Clinical Indications

  • Symptomatic and recurrent AVNRT refractory to antiarrhythmic drug therapy, or with patient intolerance/preference for definitive treatment.
  • Symptomatic and recurrent AVRT, including Wolff-Parkinson-White (WPW) Syndrome, especially with rapid ventricular response, presyncope, syncope, or a history of sudden cardiac death.
  • Symptomatic focal atrial tachycardia refractory to antiarrhythmic medications or with significant impact on quality of life.
  • Documented SVT with significant symptoms (e.g., palpitations, dizziness, shortness of breath, chest pain, fatigue) despite optimal medical management.
  • Electrophysiological evidence of a readily inducible and localized arrhythmogenic substrate amenable to ablation.

Procedure Steps

  1. Obtain informed consent, establish intravenous access, and administer conscious sedation or general anesthesia.
  2. Perform sterile preparation and draping of percutaneous catheter insertion sites (typically femoral veins and/or arteries, internal jugular, or subclavian vein).
  3. Percutaneous insertion of multiple electrophysiology catheters (e.g., diagnostic and ablation catheters) into the cardiac chambers and great vessels under fluoroscopic or intracardiac echocardiography guidance.
  4. Position catheters at key anatomical sites to record intracardiac electrograms and perform baseline electrophysiologic measurements (e.g., AH, HV intervals).
  5. Employ programmed electrical stimulation protocols from various sites (e.g., atrium, ventricle) to induce the target arrhythmia (AVNRT, AVRT, focal atrial tachycardia) and assess its mechanism.
  6. Activate a 3D electroanatomic mapping system (e.g., CARTO, EnSite, Rhythmia) to create a detailed anatomical reconstruction of the relevant cardiac chambers and overlay electrical activation maps, identifying the precise location of the accessory pathway, atrial focus, or AV nodal re-entrant pathway.
  7. Precisely localize the arrhythmogenic substrate using 3D mapping, entrainment mapping, and careful analysis of activation sequences during induced tachycardia.
  8. Deliver radiofrequency energy (heating) or cryoablation (cooling) through the ablation catheter to create focal lesions that interrupt the arrhythmogenic pathway, guided by the 3D map and local electrograms.
  9. Perform re-testing with programmed electrical stimulation after ablation to confirm non-inducibility of the target arrhythmia and resolution of accessory pathway conduction.
  10. Withdraw all catheters and achieve hemostasis at the vascular access sites.

Coding Guidelines

  • CPT 93653 is a primary procedure code for extensive EP study and ablation of AVNRT, AVRT (including WPW), and/or focal atrial tachycardia, including 3D mapping.
  • This code is inclusive of the comprehensive electrophysiologic evaluation, intracardiac recording, induction of arrhythmia, and subsequent ablation.
  • Do not report 93653 in conjunction with 93613 (right atrial pacing and recording) as these components are explicitly excluded or considered integral to the extensive evaluation described by 93653.
  • This code has a global surgical period, typically 0 or 10 days; verify with individual payers.
  • Documentation must clearly support the medical necessity for both the extensive EP evaluation and the ablation, including detailed findings from the EP study, the use of 3D mapping, the specific target arrhythmia, and confirmation of ablation success.
  • When multiple distinct ablation procedures are performed on the same day (e.g., AVNRT ablation coded with 93653 and a separate atrial fibrillation ablation coded with 93656), modifier 59 (or a more specific X-modifier such as XS, XP, XU) may be appropriate for the additional procedure if documentation supports distinct procedural sites or lesions and the payer allows separate reporting.

Associated ICD-10 Codes